CC BY-NC-ND 4.0 · J Neurol Surg A Cent Eur Neurosurg 2024; 85(06): 577-584
DOI: 10.1055/s-0043-1776707
Original Article

En Bloc Resection for Spinal Cord Hemangioblastomas: Surgical Technique and Clinical Outcomes

Xiaofeng Chen*
1   Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
2   Institute of Brain Science, Harbin Medical University, Harbin, Heilongjiang, China
3   Institute of Neuroscience, Sino-Russian Medical Research Center, Harbin Medical University, Harbin, Heilongjiang, China
,
Hua Guo*
1   Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
,
Jianli Zhang*
4   Department of Neurology, Xiamen Fifth Hospital, Xiamen, Fujian, China
,
Junyi Ye
5   Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China
,
Shurong Wang
6   Department of Neurology, Hainan Medical University, Haikou, Hainan, China
,
Haiping Jiang
7   Department of Neurosurgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China
,
Qingchun Mu
8   Department of Neurosurgery, The People's Hospital of Gaozhou of Guangdong Medical University, Maoming, Guangdong, China
,
Xiaoxiong Wang
1   Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
2   Institute of Brain Science, Harbin Medical University, Harbin, Heilongjiang, China
3   Institute of Neuroscience, Sino-Russian Medical Research Center, Harbin Medical University, Harbin, Heilongjiang, China
› Author Affiliations
Funding This work was supported by the National Natural Science Foundation of China (81902554), Postdoctoral Science Foundation of Heilongjiang Province (LBH-Z19076 and LBHZ19190), Heilongjiang Welfare Fund Organization of Disabled Persons (HJ2022-1), Youth Foundation of the First Affiliated Hospital of Harbin Medical University (HYD2020YQ0018), Fujian Provincial Department of Science and Technology Guidance Program (No. 2022D031).

Abstract

Background Spinal cord hemangioblastomas are rare benign and highly vascular tumors that develop either sporadically or as part of von Hippel–Lindau (VHL) disease. Generally, complete resection without significant neurologic deficit remains considerably challenging due to the risk of massive bleeding. The current study therefore aimed to describe en bloc resection of spinal cord hemangioblastomas according to the typical anatomical structures of peripheral lesions and evaluate the neurofunctional prognosis of this technique.

Methods A total of 39 spinal cord hemangioblastomas from a series of 19 patients who underwent en bloc resection were retrospectively analyzed. In all cases, clinical and radiologic characteristics, as well as surgical tenets, were retrospectively determined and analyzed. Short- and long-term outcomes were analyzed using the McCormick grade and Odom's criteria. Factors significantly associated with poor neurologic function after en bloc resection were also determined.

Results All 39 spinal cord hemangioblastomas, including 28 intramedullary, 2 intramedullary–extramedullary, and 9 extramedullary lesions, were located dorsally or dorsolaterally (100.0%). The most common lesion location was the thoracic segment (53.8%), with most of the lesions being accompanied by syringomyelia (94.7%). Long-term follow-up (mean: 103 ± 50.4 months) for prognosis determination revealed that 88.2% (15/17) of all cases had stable or improved neurofunctional outcomes according to the McCormick grade and Odom's criteria. Only one case with VHL disease developed recurrence 4 years after surgery. Additionally, statistical analysis showed that VHL disease was an independent prognostic factor associated with deteriorating neurologic function (p = 0.015).

Conclusions En bloc resection facilitated satisfactory long-term functional outcomes in patients with spinal cord hemangioblastomas. Given that VHL disease was identified as a predictor of poor long-term outcomes, regular long-term follow-up of patients with VHL-associated spinal cord hemangioblastoma seems necessary.

Ethics approval

The study was approved by the ethics committee of the First Affiliated Hospital of Harbin Medical University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the First Affiliated Hospital of Harbin Medical University and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.


Author Contributions

X.C., H.G., and J.Z. contributed to the conceptualization, design, methodology, and writing and editing of the manuscript. S.W. and J.Y. were responsible for formal analysis and provided administrative, technical, or material support. X.W., H.J., and Q.M. contributed to the methodology and supervision of the study. They also contributed to writing, reviewing, editing, and revision of the manuscript.


* These authors contributed equally to this work.




Publication History

Received: 24 March 2023

Accepted: 31 August 2023

Article published online:
22 November 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Mehta GU, Asthagiri AR, Bakhtian KD, Auh S, Oldfield EH, Lonser RR. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease. J Neurosurg Spine 2010; 12 (03) 233-242
  • 2 Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 2001; 48 (01) 55-62 , discussion 62–63
  • 3 Latif F, Tory K, Gnarra J. et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260 (5112) 1317-1320
  • 4 Vortmeyer AO, Gnarra JR, Emmert-Buck MR. et al. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 1997; 28 (05) 540-543
  • 5 Lonser RR, Glenn GM, Walther M. et al. von Hippel-Lindau disease. Lancet 2003; 361 (9374) 2059-2067
  • 6 Mandigo CE, Ogden AT, Angevine PD, McCormick PC. Operative management of spinal hemangioblastoma. Neurosurgery 2009; 65 (06) 1166-1177
  • 7 Kanno H, Yamamoto I, Nishikawa R. et al; Clinical VHL Research Group in Japan. Spinal cord hemangioblastomas in von Hippel-Lindau disease. Spinal Cord 2009; 47 (06) 447-452
  • 8 Deng X, Wang K, Wu L. et al. Intraspinal hemangioblastomas: analysis of 92 cases in a single institution: clinical article. J Neurosurg Spine 2014; 21 (02) 260-269
  • 9 Melmon KL, Rosen SW. Lindau's disease. review of the literature and study of a large kindred. Am J Med 1964; 36: 595-617
  • 10 Imagama S, Ito Z, Wakao N. et al. Differentiation of localization of spinal hemangioblastomas based on imaging and pathological findings. Eur Spine J 2011; 20 (08) 1377-1384
  • 11 Siller S, Szelényi A, Herlitz L, Tonn JC, Zausinger S. Spinal cord hemangioblastomas: significance of intraoperative neurophysiological monitoring for resection and long-term outcome. J Neurosurg Spine 2017; 26 (04) 483-493
  • 12 Lee DK, Choe WJ, Chung CK, Kim HJ. Spinal cord hemangioblastoma: surgical strategy and clinical outcome. J Neurooncol 2003; 61 (01) 27-34
  • 13 Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI. Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery 2001; 49 (02) 321-327 , discussion 327–328
  • 14 Xu QW, Bao WM, Mao RL, Yang GY. Magnetic resonance imaging and microsurgical treatment of intramedullary hemangioblastoma of the spinal cord. Neurosurgery 1994; 35 (04) 671-675 , discussion 675–676
  • 15 Sadashivam S, Abraham M, Kesavapisharady K, Nair SN. Long-term outcome and prognostic factors of intramedullary spinal hemangioblastomas. Neurosurg Rev 2020; 43 (01) 169-175
  • 16 Xie T, Qian J, Zhang L, Luo C. Microsurgical resection of intramedullary spinal cord hemangioblastomas: 3-dimensional operative video. Neurosurgery 2014; 10 (Suppl. 01) 160 , discussion 160
  • 17 Dwarakanath S, Sharma BS, Mahapatra AK. Intraspinal hemangioblastoma: analysis of 22 cases. J Clin Neurosci 2008; 15 (12) 1366-1369
  • 18 Parker F, Aghakhani N, Ducati LG. et al. Results of microsurgical treatment of medulla oblongata and spinal cord hemangioblastomas: a comparison of two distinct clinical patient groups. J Neurooncol 2009; 93 (01) 133-137